Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease. (Q37249125)
Jump to navigation
Jump to search
scientific article published on October 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease. |
scientific article published on October 2013 |
Statements
Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease (English)
Mika Shimoji
Juan Wang
Salim Shah
Edward R Biehl
Seung Lim
Allison Chang
Kathleen A Maguire-Zeiss
Xiaomin Su
Howard J Federoff
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference